Every state, kept current
The Rates plan
$29/mo7-day free trialThis page shows one representative rate per state for Q5141. Full schedules include every locality, modifier, and age-band variant.
- Every code on all 51 published schedules
- Full-schedule CSV export and state network lists
- Email alerts when a state changes its rates
$29/mo after the trial. Cancel anytime.
Publishing states
16
Median % of Medicare
--
Rate range
$6.49 - $51.90
Q5141 rates in every publishing state
| State | Medicaid rate | % of Medicare | Prior auth | Vintage |
|---|---|---|---|---|
| Alabama | $23.70 | -- | -- | 2026 |
| Arkansas | $43.57* | -- | -- | 2026 |
| Arizona | $11.00 | -- | -- | 2025 |
| Indiana | $6.81 | -- | Required | 2025 |
| Kansas | $6.49 | -- | -- | 2025 |
| Kentucky | $43.57 | -- | -- | 2026 |
| Minnesota | $13.23 | -- | Required | 2025 |
| Mississippi | $34.86 | -- | -- | 2025 |
| Montana | $13.75 | -- | -- | 2026 |
| New Hampshire | $25.95 | -- | Not required | 2026 |
| New Jersey | $27.83 | -- | Not required | 2026 |
| New Mexico | $43.57 | -- | -- | 2025 |
| Oklahoma | $51.90 | -- | -- | 2026 |
| Texas | $9.67* | -- | -- | 2026 |
| Utah | $6.49* | -- | Required | 2026 |
| Wisconsin | $51.90 | -- | -- | 2025 |
Published Medicaid fee-for-service schedule amounts, not a coverage or eligibility guarantee. Managed-care plan rates can differ. Where no prior-authorization flag is shown, the state does not publish one. Rows marked * are representative published variants or methodology-derived rates. "--" in the prior-auth column means the state publishes no PA flag.
Related state-specific services codes
- C1716 - Brachytherapy source, non-stranded, gold-198, per source
- C1717 - Brachytherapy source, non-stranded, high dose rate iridium-192, per source
- C1719 - Brachytherapy source, non-stranded, non-high dose rate iridium-192, per source
- C2616 - Brachytherapy source, non-stranded, yttrium-90, per source
- C2634 - Brachytherapy source, non-stranded, high activity, iodine-125, greater than 1.01 mci (nist), per source
- C2635 - Brachytherapy source, non-stranded, high activity, palladium-103, greater than 2.2 mci (nist), per source
- C2636 - Brachytherapy linear source, non-stranded, palladium-103, per 1 mm
- C2638 - Brachytherapy source, stranded, iodine-125, per source
All 56 codes from Q5098 to Q5167 or every state-specific services code by number.
Frequently asked questions
How much does Medicaid pay for Q5141?
16 state Medicaid programs publish a fee-for-service rate for Q5141 (injection, adalimumab-aaty, biosimilar, 1 mg), ranging from $6.49 in Utah to $51.90 in Oklahoma. The full table on this page lists every publishing state's current rate.
Which state pays the most for Q5141?
Oklahoma publishes the highest Medicaid rate for Q5141 at $51.90. Utah publishes the lowest at $6.49.
Does Q5141 require prior authorization under Medicaid?
3 of the 16 publishing states flag Q5141 as requiring prior authorization (always or conditionally) on their fee schedules. States without a flag publish no PA indicator for this code - that means "not published", not "no PA required".